Effect of Metformin on miR-146a Expression by Grout, S. Jackson et al.
Cedarville University
DigitalCommons@Cedarville
The Research and Scholarship Symposium The 2017 Symposium
Apr 12th, 11:00 AM - 2:00 PM
Effect of Metformin on miR-146a Expression
S. Jackson Grout
Cedarville University, stevengrout@cedarville.edu
Bryce C. MacTurk
Cedarville University, bcmacturk@cedarville.edu
Amanda D. Sims
Cedarville University, asims@cedarville.edu
Kaleb M. Pauley
Cedarville University, kpauley@cedarville.edu
Follow this and additional works at: http://digitalcommons.cedarville.edu/
research_scholarship_symposium
Part of the Biology Commons, and the Immunology and Infectious Disease Commons
This Poster is brought to you for free and open access by
DigitalCommons@Cedarville, a service of the Centennial Library. It has
been accepted for inclusion in The Research and Scholarship Symposium
by an authorized administrator of DigitalCommons@Cedarville. For more
information, please contact digitalcommons@cedarville.edu.
Grout, S. Jackson; MacTurk, Bryce C.; Sims, Amanda D.; and Pauley, Kaleb M., "Effect of Metformin on miR-146a Expression"
(2017). The Research and Scholarship Symposium. 38.
http://digitalcommons.cedarville.edu/research_scholarship_symposium/2017/poster_presentations/38
MiR-146a Upregulation of Phagocytosis in Human Macrophages 
 
Sjögrens Syndrome (SjS) is an autoimmune disease that attacks exocrine glands such as salivary 
and lacrimal glands resulting in severe dryness of the mouth and eyes. Previous studies have 
linked increased microRNA-146a (miR-146a) expression in peripheral blood mononuclear cells in 
SjS patients compared to healthy controls. MicroRNAs (miRNAs), small non-coding RNA 
molecules that post-transcriptionally regulate gene expression, are known to play key regulatory 
roles in immune responses and have been implicated in a growing number of autoimmune 
disorders. Further investigation into the role of increased miR-146a expression in SjS revealed 
links to several immune functions including phagocytosis.Our goal was to further examine the 
relationship between miR-146a expression and the rate of phagocytosis in human macrophages 
by using apoptotic human cells as a phagocytic target. We hypothesized that upregulation of miR-
146a would increase phagocytic activity of differentiated THP-1 human monocytes. To quantify 
phagocytic activity, a pH-sensitive fluorescent dye (pHrodo) was used to indicate the E. coli or 
apoptotic Jurkats that had been phagocytosed. THP-1 cells were transfected with miR-146a and 
differentiated into macrophages. Phagocytic activity was observed by incubating fluorescently 
labeled E.coli or apoptotic Jurkat cells with miR-146a transfected and mock transfected THP-1 
cells for 2-4 hours. Fluorescence intensity was quantified using a fluorescent plate reader (E. coli) 
and microscopy (apoptotic Jurkats). MiR-146a-transfected THP-1 cells exhibited significantly 
increased phagocytic activity of fluorescently labeled E. coli (P<0.001) and apoptotic Jurkats. 
Knockdown of TRAF6, a gene target of miR-146a, did not impact the phagocytic activity. MiR-
146a appears to upregulate phagocytic activity in human THP-1 cells through an unknown 
mechanism. Further studies are in progress to determine the mechanism by which miR-146a 
upregulates phagocytosis. 
